Madrazo Cabo José Manuel, Villavicencio Flores Ania, Chagollán Gudiño Paulina, Monter Valera Nuvia Adriana, Velasco Bárcena Jose Antonio, Sedeño Monge Virginia
Department of Gynecology and Obstetrics, Hospital Angeles, Puebla, Mexico.
Deanery of Medical Sciences, Faculty of Medicine, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico.
Am J Case Rep. 2025 Apr 17;26:e945578. doi: 10.12659/AJCR.945578.
BACKGROUND Antiphospholipid syndrome (APS) is an immune system disorder that causes an increased risk of blood clots and has been associated with the development of hypothyroidism and double mitral lesion, possibly due to immune complex deposition. This report describes a 34-year-old woman presenting with hypothyroidism and antiphospholipid syndrome with a double mitral lesion at 26 weeks of gestation. CASE REPORT We report the case of a 34-year-old woman with a history of hyperthyroidism that evolved into primary hypothyroidism, as well as APS under medical treatment, and fetal death during her first pregnancy. Subsequently, at 26 weeks of gestation in her second pregnancy, she presented a clinical picture of respiratory failure and precordial pain, which persisted with the same intensity and location despite postural changes for 2 days; after that, she had an increase in chest pain with irradiation to the front part of the chest, progressing to orthopnea. She was evaluated in the emergency room by Cardiology, where an echocardiogram was performed, which showed a double mitral lesion. The decision was made to admit her to intensive care with this diagnosis and pulmonary edema and establishing the specific treatment. She remained under obstetric surveillance and cardiovascular treatment until she was discharged. She maintained maternal-fetal stability cardiologic and endocrinological care, allowing the pregnancy to be successfully carried out to term without complications, and she and her baby showed very good perinatal results during the postpartum period. CONCLUSIONS This report highlights the importance of timely and accurate diagnosis of antiphospholipid syndrome and highlights the association with both hypothyroidism and double mitral lesion.
抗磷脂综合征(APS)是一种免疫系统疾病,会增加血栓形成风险,且可能由于免疫复合物沉积,与甲状腺功能减退和二尖瓣双病变的发生有关。本报告描述了一名34岁女性,在妊娠26周时出现甲状腺功能减退和抗磷脂综合征伴二尖瓣双病变。
我们报告一例34岁女性病例,其有甲状腺功能亢进病史,后发展为原发性甲状腺功能减退,同时接受抗磷脂综合征治疗,且首次怀孕时发生胎儿死亡。随后,在其第二次怀孕的26周时,她出现呼吸衰竭和心前区疼痛的临床表现,尽管体位改变2天,疼痛强度和部位仍未改变;此后,她胸痛加重并放射至胸前部,进而发展为端坐呼吸。她在急诊室接受心脏病学评估,进行了超声心动图检查,结果显示二尖瓣双病变。决定以该诊断及肺水肿收治她入重症监护病房并确定具体治疗方案。她一直处于产科监护和心血管治疗之下,直至出院。她在心脏和内分泌护理方面维持了母婴稳定,使妊娠得以顺利足月进行且无并发症,产后她和婴儿的围产期结果非常良好。
本报告强调了及时准确诊断抗磷脂综合征的重要性,并突出了其与甲状腺功能减退和二尖瓣双病变的关联。